Publications by authors named "Ismail Hanta"

Claim this Profile
G
Geriatric nutrition risk index as an indicator of acute exacerbation and mortality risk in patients with idiopathic pulmonary fibrosis.
Pelin Pınar Deniz, İsmail Hanta, Pelin Duru Çetinkaya, Sedef Küçükyalçın

BMC Geriatr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors.
Efraim Guzel, Ismail Hanta, Oya Baydar Toprak, Okan Gurbuz, Burak Mete

Medicina (Kaunas)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cough burden and quality of life in patients with progressive pulmonary fibrosis: A multicenter observational study.
Aykut Cilli, Fatih Uzer, Sevda Sener Comert, Nesrin Ocal, Dildar Duman, Ismail Hanta

Respir Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship Between Chest Wall Muscle Thickness, Pulmonary Function, and Prognostic Markers in Idiopathic Pulmonary Fibrosis.
Pelin Pınar Deniz, Sevgül Köse, İsmail Hanta, Pelin Duru Çetinkaya, Merisa Sinem Arslan

Medicina (Kaunas)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis.
Nesrin Ocal, Aykut Cilli, Nesrin Mogulkoc, Funda Coskun, Ahmet Ursavas, Ismail Hanta

Ann Thorac Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of TOLLIP mRNA Expression and TOLLIP rs5743899A/G, TOLLIP rs3750920C/T, and IL-10 -1082G/A Single-Nucleotide Polymorphisms with Susceptibility to Tuberculosis.
Togrul Nagiyev, Emel Eker, Ali Uckayabasi, Ismail Hanta, Begum Kayar

Curr Microbiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 18F-FDG-PET/CT scans in patients diagnosed with sarcoidosis and tuberculosis.
Pelin Pinar Deniz, Pelin Duru Çetinkaya, İsmail Hanta, Merisa Sinem Arslan, İsa Burak Güney

Medicine (Baltimore)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Frequency of Mediastinal Lymph Node Calcification in Sarcoidosis Patients and the Influencing Factors.
Pelin Pınar Deniz, Pelin Duru Çetinkaya, Saida Mehdiyeva, İsmail Hanta

Medicina (Kaunas)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of quality of life in IPF Patients: a multicenter observational study.
Fatih Uzer, Aykut Cilli, Ismail Hanta, Funda Coskun, Can Sevinc

Sarcoidosis Vasc Diffuse Lung Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between nailfold capillaroscopy findings and the etiology and prognosis of interstitial lung disease.
Şerife Şeyda Zengin Acemoğlu, İpek Türk, Pelin Pınar Deniz, Mehmet Ali Aşık, Didem Arslan, İsmail Hanta

Clin Rheumatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-Up.
Ozgecan Kayalar, Pelin Duru Cetinkaya, Vahap Eldem, Serap Argun Baris, Nurdan Kokturk, Ismail Hanta

Viruses· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular damage evaluation based on nailfold videocapillarosopy in sarcoidosis.
Şerife Şeyda Zengin Acemoğlu, İpek Türk, Mehmet Ali Aşık, Ayşegül Özdoğan Bircan, Pelin Pınar Deniz, İsmail Hanta

Clin Rheumatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions.
Aykut Cilli, Nesrin Ocal, Fatih Uzer, Funda Coskun, Can Sevinc, Ismail Hanta

Respir Investig· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transatrial balloon atrial septostomy to facilitate weaning off venoarterial ECMO after pulmonary endarterectomy.
Koray Ak, Gökhan Arslanhan, Yakup Tire, Sinan Tosun, Alper Kararmaz, İsmail Hanta

Int J Artif Organs· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort.
Cenk Babayigit, Nurdan Kokturk, Seval Kul, Pelin Duru Cetinkaya, Sibel Atis Nayci, Ismail Hanta

Front Med (Lausanne)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study.
Aykut Cilli, Ismail Hanta, Fatih Uzer, Funda Coskun, Can Sevinc

Respir Med Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy and safety of pirfenidone 200 mg tablets in patients with idiopathic pulmonary fibrosis in a real-life setting.
Funda Coşkun, Aykut Çilli, İsmail Hanta, Can Sevinç, Ayşe Ödemiş

Turk J Med Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study.
Mehmet Serdar Küçükoğlu, İsmail Hanta, Bahri Akdeniz, Sümeyye Güllülü, Ersan Atahan

Anatol J Cardiol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells.
Yasemin Saygideger, Aycan Sezan, Aslihan Candevir, Burcu Saygıdeğer Demir, Efraim Güzel, Ismail Hanta

Cancer Treat Res Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the COVID-19 pandemic on the follow-up and treatment of patients with idiopathic pulmonary fibrosis: a cross-sectional, multicentre phone call survey.
Funda Coskun, Ismail Hanta, Aykut Cilli, Guven Ozkaya, Ahmet Ursavas

BMJ Open· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.
Nurdan Kokturk, Cenk Babayigit, Seval Kul, Pelin Duru Cetinkaya, Sibel Atis Nayci, Ismail Hanta

Respir Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and mortality of surgical lung biopsy in the diagnosis of usual interstitial pneumonia.
Aykut Cilli, Celalettin Kocaturk, Kemal C Tertemiz, Cem E Kalafat, Ismail Hanta

ANZ J Surg· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Patients with Fibrotic Interstitial Lung Disease: Preliminary results from the Turk-UIP Study.
Musellim Benan, Mogulkoc Nesrin, Uzun Oguz, Tokgoz Akyil Fatma, Turktas Haluk, Hanta Ismail

Turk Thorac J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of plasma copeptin level for diagnosis and mortality of pulmonary embolism.
Caglar Ozmen, Onur Sinan Deveci, Muhammet Bugra Karaaslan, Oya Baydar, Anil Akray, Ismail Hanta

Rev Assoc Med Bras (1992)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness, Safety, and Tolerability of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Retrospective Study.
Ismail Hanta, Aykut Cilli, Can Sevinc

Adv Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis